Gao's Triple Eversion Carotid Endarterectomy

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Dec 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new surgical technique called Gao's Triple Eversion Carotid Endarterectomy (GTE-CEA) to treat patients with carotid artery stenosis, which is a condition where the arteries in the neck become narrowed due to plaque buildup. This innovative approach aims to help those with complex cases of tandem carotid lesions, which are difficult to treat with traditional methods. The trial is currently looking for participants who have significant narrowing in their carotid arteries—specifically, those with more than 70% blockage that isn’t causing symptoms, or more than 50% blockage that is causing symptoms.

To be eligible for this trial, participants must meet certain criteria, including having a specific level of artery narrowing confirmed by imaging tests. Those who do not meet these criteria, such as having less severe narrowing, will not be considered for the study. Participants can expect to undergo the GTE-CEA procedure and will be monitored for their recovery and outcomes. This trial is open to individuals of all genders and is currently recruiting patients. If you or a loved one have been diagnosed with carotid artery stenosis and meet the eligibility requirements, this could be an opportunity to explore a new treatment option.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Meet the diagnostic criteria for TCL stenosis.
• • Above 70% asymptomatic CCA and ICA stenosis or \> 50% symptomatic CAS confirmed by DSA or CTA before surgery
• Exclusion Criteria:
• • Did not meet the diagnostic criteria for CAS
• • Asymptomatic CAS \< 50% (as confirmed by DSA or CTA before surgery)
• • With stenosis at the opening of the CCA.